From Vor Nabs $110M to Spare Healthy Cells From Targeted Cancer Drugs:

5-Vor-Biopharma-2019.11.07-_Genevieve-de-Manio-Photography_
5-Vor-Biopharma-2019.11.07-_Genevieve-de-Manio-Photography_

Headshot courtesy of Vor Biopharma